Weil am Rhein, Germany

Birgit Bollbuck

USPTO Granted Patents = 6 


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Weil am Rhein, DE (2009 - 2014)
  • Munich, DE (2018 - 2022)

Company Filing History:


Years Active: 2009-2025

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):

Title: Birgit Bollbuck: Innovator in Pharmaceutical Chemistry

Introduction

Birgit Bollbuck is a prominent inventor based in Weil am Rhein, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug candidates. With a total of 6 patents to her name, her work focuses on innovative compounds that have the potential to treat various diseases.

Latest Patents

Among her latest patents, Birgit has developed heteroaryl butanoic acid derivatives. These compounds are recognized as promising drug candidates, especially concerning leukotriene A4 hydrolase (LTA4H). The inventions also encompass pharmaceutical compositions that include these novel derivatives, methods for utilizing these compounds in treating various diseases and disorders, and processes for preparing these innovative compounds.

Career Highlights

Birgit has worked with notable companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research in drug development.

Collaborations

Throughout her career, Birgit has collaborated with esteemed colleagues such as Christian Markert and Wolfgang Miltz. These partnerships have further enhanced her research and innovation in the pharmaceutical field.

Conclusion

Birgit Bollbuck stands out as a dedicated inventor whose work in pharmaceutical chemistry continues to pave the way for new therapeutic options. Her innovative contributions and collaborations reflect her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…